June 27, 2024

U.S. Sen. Marsha Blackburn (R-TN) led a bipartisan group of senators in a communication to the Centers for Medicare and Medicaid Services (CMS) requesting the agency improve patients’ access to positron emission tomography (PET) and single photon emission computed tomography (SPECT) scans by addressing inadequate packaging of payment for diagnostic radiopharmaceuticals used in diagnostic scans.

These scans help physicians identify certain diseases more effectively, including Alzheimer’s, Parkinson’s, advanced cardiovascular disease and prostate cancer.

The American College of Radiology® (ACR®) long supported addressing the packaging of payment for diagnostic radiopharmaceuticals so that beneficiaries have access to the care they need. The College continues to advocate with other organizations to ensure CMS includes something on this issue in upcoming rulemaking.

For questions, contact Ashley Walton, ACR Government Affairs Director.


Related ACR News

  • ACR Highlights Imaging Payment Changes in HOPPS Final Rule

    ACR outlines key radiology updates in CMS 2026 HOPPS final rule, including payment changes and quality reporting updates effective Jan. 1.

    Read more
  • ACR Provides Input to FDA on AI Measurement and Evaluation

    ACR submitted comments to FDA on real-world AI device performance, stressing safety, governance, and continuous monitoring.

    Read more
  • Radiology’s Fight Against Prior Authorization Delays

    ACR is leading national efforts to make prior authorization more efficient and clinically appropriate while reducing the administrative burden and supporting national legislation.

    Read more